Lorianne Auger, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 815 W 2000 N, Layton, UT 84041 Phone: 801-773-6478 Fax: 801-773-6478 |
Dr. Kenneth L Ernstrom, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2065 N Robins Drive, Layton, UT 84041 Phone: 801-773-3863 |
Linh Chi Hoang Do Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1171 W 2000 N, Layton, UT 84041 Phone: 801-614-1302 Fax: 801-614-1328 |
Brian Cecil John, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2486 W 900 N, Layton, UT 84041 Phone: 435-538-0802 |
Mr. Robert Kelly Hansen, RPH Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 514 Peregrine Cv, Layton, UT 84040 Phone: 801-510-5665 |
Dr. Stefen Ray Osborn, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1171 W 2000 N, Layton, UT 84041 Phone: 801-599-9161 |
Mr. Craig Crippen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 W Hill Field Rd, Layton, UT 84041 Phone: 801-444-6657 |
Nolan D Barnett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1171 W 2000 N, Layton, UT 84041 Phone: 801-614-1302 Fax: 801-614-1328 |
Dr. Jebadiah Cody Blackham, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 N Fairfield Rd, Layton, UT 84041 Phone: 801-546-6352 Fax: 801-546-3754 |
Mr. Gary John Dawson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2075 N 1200 W, Layton, UT 84041 Phone: 801-779-6210 Fax: 801-779-6208 |
Dr. Kathleen A Falk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 815 W 2000 N, T-1750, Layton, UT 84041 Phone: 801-773-6478 |
Julie Lamar Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1170 E Gentile St, Layton, UT 84040 Phone: 801-546-3497 Fax: 801-544-1440 |
Melissa G. Holbrook, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 142 Blue Sage Ln, Layton, UT 84040 Phone: 801-544-0690 |
Eric Dale Swensen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1055 W Hill Field Rd, Layton, UT 84041 Phone: 801-444-6657 Fax: 801-444-6659 |
Greg Hancock, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2075 N 1200 W, Layton, UT 84041 Phone: 801-779-6210 Fax: 801-779-6208 |
Blake Cody Cook, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 N Fairfield Rd, Layton, UT 84041 Phone: 801-546-6352 |
Dr. Casey Gayland Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 W Antelope Dr, Layton, UT 84041 Phone: 801-807-7118 |
Ryan James Manning Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1171 W 2000 N, Layton, UT 84041 Phone: 801-614-1302 |
Brian Montoya, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 50 S Fort Ln, Layton, UT 84041 Phone: 801-544-1570 |
Matthew Perczak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1356 E Highway 193, Layton, UT 84040 Phone: 801-771-2994 |
News Archive
A federal grant will allow Johns Hopkins researchers to purchase a powerful $2 million computer that will speed up their efforts to find new ways to diagnose and treat brain disease, heart illnesses, cancer and other medical ailments.
Adolescents and young adults are most likely to abuse prescription medications. Yet prescription rates for controlled medications, or drugs the Drug Enforcement Administration deems as having the potential for abuse, have nearly doubled for those age groups in the past 14 years, according to a recent study published in Pediatrics. Overall, a controlled medication was prescribed for young adults at approximately one out of every six visits and for young adult by adolescents one out of every nine encounters.
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.
Lilly released results today from a Phase II study evaluating Lilly Oncology's tasisulam, a novel anti-cancer agent, in patients with metastatic melanoma, the deadliest form of skin cancer. Study results will be presented during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. on June 6, 2010.
Black people with cancer are up to twice as likely as other races to die from their disease. While disparities exist for nearly every common cancer type, the largest differences occur among cancers that benefit most from treatment - suggesting that black patients are not getting needed lifesaving treatments, according to a review from researchers at the University of Michigan Comprehensive Cancer Center.
› Verified 5 days ago